Re: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of the National Cancer Institute

• Publication date

  1999-01-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNCI/91.1.90APMID 9890178
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Journal of the National Cancer Institute, Vol. 29, 1962: Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance.

  2009cited by this paper
• Correspondence to:

  2000cited by this paper
• Hemophagocytic syndrome in five patients with Epstein–Barr virus negative B‐cell lymphoma

  1999cited by this paper
• Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

  1998cited by this paper
• Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

  1998cited by this paper
• Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

  1998cited by this paper
• Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.

  1998cited by this paper
• Tumour biological features of BRCA1-induced breast and ovarian cancer.

  1997cited by this paper
• BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

  1997cited by this paper

• Advances in Risk Management and Screening for Women at Increased Risk of Breast Cancer: The Role of MR Imaging and Personalised Approaches

  2025cites this paper
• Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study.

  2023cites this paper
• PARP inhibitors as single agents and in combination therapy: the most promising treatment strategies in clinical trials for BRCA-mutant ovarian and triple-negative breast cancers

  2022cites this paper
• Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers.

  2021cites this paper
• High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.

  2009cites this paper
• BRCA1 Mutation and Young Age Predict Fast Breast Cancer Growth in the Dutch, United Kingdom, and Canadian Magnetic Resonance Imaging Screening Trials

  2007cites this paper
• BRCA Mutations in Women with Ductal Carcinoma In situ

  2007cites this paper
• Characterization of Familial Non-BRCA1/2 Breast Tumors by Loss of Heterozygosity and Immunophenotyping

  2006cites this paper
• Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance.

  2006cites this paper
• Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.

  2005cites this paper
• Placental Cadherin and the Basal Epithelial Phenotype of BRCA1-Related Breast Cancer

  2005cites this paper
• Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

  2005cites this paper
• Estrogen Receptor Status in BRCA1- and BRCA2-Related Breast Cancer

  2004cites this paper
• Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers

  2004cites this paper
• BRCA1/2 testing: complex themes in result interpretation.

  2001cites this paper
• Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients.

  2001cites this paper
• Conceptos básicos en biología molecular del cáncer. Susceptibilidad gené- tica Basic concepts in the molecular biology of cancer. Genetic suscepti- bility

  2001cites this paper
• Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients

  2001cites this paper
• Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer.

  2000cites this paper
• Clinical management of BRCA1- and BRCA2-associated breast cancer.

  2000cites this paper
• Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer.

  2000cites this paper
• Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer

  2000cites this paper
• Tamoxifen prevention of breast cancer: an instance of the fingerpost.

  1999cites this paper
• More about: multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

  1999cites this paper